Biodexa Pharmaceuticals Plc
BDRX · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $20 | $4 | $0 |
| - Cash | $4 | $2 | $5 | $6 |
| + Debt | $1 | $1 | $0 | $0 |
| Enterprise Value | -$4 | $19 | -$0 | -$5 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$2 | -$3 | -$2 | -$2 |
| % Margin | – | – | – | -2,612% |
| EBITDA | -$4 | -$5 | -$3 | -$2 |
| % Margin | – | – | – | -2,755.4% |
| Net Income | -$4 | -$2 | -$3 | -$4 |
| % Margin | – | – | – | -4,230.1% |
| EPS Diluted | -150,600 | -36,500 | -79,200 | -11,300 |
| % Growth | -312.6% | 53.9% | -600.9% | – |
| Operating Cash Flow | -$3 | -$7 | -$5 | -$3 |
| Capital Expenditures | -$0 | -$1 | $0 | -$0 |
| Free Cash Flow | -$3 | -$8 | -$5 | -$3 |